XJB-5-131
XJB-5-131 is a synthetic mitochondria-targeted antioxidant designed to combat oxidative stress. It is a member of the JP4-039 family of compounds, which are known for their ability to protect cells from damage caused by free radicals. XJB-5-131 has been studied for its potential applications in the treatment of various diseases, including neurodegenerative diseases, cancer, and ischemia-reperfusion injury.
Structure and Mechanism[edit | edit source]
XJB-5-131 is a lipophilic cation that is selectively taken up by mitochondria due to the organelle's negative membrane potential. Once inside the mitochondria, XJB-5-131 acts as a free radical scavenger, neutralizing harmful reactive oxygen species (ROS) and preventing oxidative damage to mitochondrial components.
Therapeutic Potential[edit | edit source]
Neurodegenerative Diseases[edit | edit source]
XJB-5-131 has shown promise in preclinical studies for the treatment of neurodegenerative diseases. In models of Parkinson's disease, it has been found to protect dopaminergic neurons from degeneration. Similarly, in models of Huntington's disease, XJB-5-131 has been shown to reduce neuronal death and improve motor function.
Cancer[edit | edit source]
In cancer research, XJB-5-131 has been studied for its potential to protect healthy cells from the toxic effects of radiation therapy. It has been found to selectively protect non-cancerous cells, while leaving cancer cells vulnerable to radiation damage.
Ischemia-Reperfusion Injury[edit | edit source]
XJB-5-131 has also been investigated for its potential to mitigate ischemia-reperfusion injury, a type of tissue damage caused by the restoration of blood supply after a period of ischemia. In animal models, it has been shown to reduce tissue damage and improve survival rates.
Safety and Tolerability[edit | edit source]
In preclinical studies, XJB-5-131 has been found to be well-tolerated with no significant adverse effects reported. However, further studies are needed to fully assess its safety profile in humans.
See Also[edit | edit source]
- JP4-039
- Mitochondria-targeted antioxidants
- Oxidative stress
- Neurodegenerative diseases
- Cancer
- Ischemia-reperfusion injury
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
